Inhibikase Therapeutics, Inc.
IKT
$1.44
$0.032.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.80% | -5.92% | -4.47% | 2,907.26% | -59.15% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.70% | -27.50% | 13.16% | 213.21% | -22.81% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 31.71% | 508.00% | -27.09% | -84.61% | 108.42% |
| Total Current Assets | -11.55% | -5.70% | -4.35% | 2,249.62% | -51.29% |
|
|
|||||
| Total Current Assets | -11.55% | -5.70% | -4.35% | 2,249.62% | -51.29% |
| Net Property, Plant & Equipment | -100.00% | -49.74% | -21.48% | -20.50% | -16.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -10.42% | -5.76% | -4.38% | 2,152.73% | -50.41% |
|
|
|||||
| Total Accounts Payable | -77.05% | 59.78% | 79.44% | -62.72% | 88.68% |
| Total Accrued Expenses | 16.23% | -10.45% | 31.09% | 23.99% | 6.24% |
| Short-term Debt | -- | -- | -- | -- | -59.56% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -49.33% | -32.31% | -23.90% | -4.60% |
| Total Finance Division Other Current Liabilities | -16.93% | -10.96% | -- | -- | -- |
| Total Other Current Liabilities | -16.93% | -10.96% | -- | -- | -- |
| Total Current Liabilities | -23.90% | 2.91% | 129.02% | -23.92% | 32.47% |
|
|
|||||
| Total Current Liabilities | -23.90% | 2.91% | 129.02% | -23.92% | 32.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -59.56% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -23.90% | 2.91% | 129.02% | -23.92% | 31.56% |
|
|
|||||
| Common Stock & APIC | 2.41% | 2.19% | 2.38% | 131.57% | 0.18% |
| Retained Earnings | -10.11% | -9.17% | -14.49% | -14.74% | -7.55% |
| Treasury Stock & Other | -44.83% | -190.00% | 97.31% | -2,166.67% | 280.00% |
| Total Common Equity | -8.94% | -6.62% | -9.63% | 17,979.06% | -110.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.94% | -6.62% | -9.63% | 17,979.06% | -110.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.94% | -6.62% | -9.63% | 17,979.06% | -110.41% |
|
|
|||||